(Q45873554)

English

Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia

scientific article published in March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

0 references

1 reference

based on heuristic

inferred from title

Christof von Kalle

13

object named as

Christof von Kalle

1 reference

Europe PubMed Central

17 December 2017

Cynthia E. Dunbar

object named as

Cynthia E Dunbar

20

0 references

Manfred Schmidt

14

object named as

Manfred Schmidt

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Hans-Peter Kiem

1

object named as

Hans-Peter Kiem

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

author name string

Stephanie Sellers

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Bobbie Thomasson

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Julia C Morris

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

John F Tisdale

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Peter A Horn

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Peiman Hematti

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Rima Adler

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Ken Kuramoto

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Boris Calmels

10

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Aylin Bonifacino

11

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Jiong Hu

12

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Brian Sorrentino

15

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Arthur Nienhuis

16

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

C Anthony Blau

17

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Robert G Andrews

18

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Robert E Donahue

19

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

publication date

1 March 2004

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Molecular Therapy

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

389-395

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Occurrence of leukaemia following gene therapy of X-linked SCID.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Polyclonal long-term repopulating stem cell clones in a primate model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Gene transfer into baboon repopulating cells: A comparison of Flt-3 Ligand and megakaryocyte growth and development factor versus IL-3 during ex vivo transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Plasticity and hematopoiesis: Circe's transforming potion?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Direct comparison of RD114-pseudotyped versus amphotropic-pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Pharmacologically regulated in vivo selection in a large animal

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Side effects of retroviral gene transfer into hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Transcription start regions in the human genome are favored targets for MLV integration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

New genes involved in cancer identified by retroviral tagging

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Evidence that hematopoiesis may be a stochastic process in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

A model for predicting the risk of cancer consequent to retroviral gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Prolonged multilineage clonal hematopoiesis in a rhesus recipient of CD34 positive cells marked with a RD114 pseudotyped oncoretroviral vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Antigen CD34+ marrow cells engraft lethally irradiated baboons

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.006

7 January 2021

Identifiers

10.1016/J.YMTHE.2003.12.006

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15006605

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45873554&oldid=2087783264"